These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22964391)

  • 1. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants.
    Sax G; Winter G
    J Control Release; 2012 Oct; 163(2):187-94. PubMed ID: 22964391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery.
    Stanković M; de Waard H; Steendam R; Hiemstra C; Zuidema J; Frijlink HW; Hinrichs WL
    Eur J Pharm Sci; 2013 Jul; 49(4):578-87. PubMed ID: 23707467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo biodegradation of extruded lipid implants in rabbits.
    Sax G; Kessler B; Wolf E; Winter G
    J Control Release; 2012 Oct; 163(2):195-202. PubMed ID: 22964393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
    Windbergs M; Strachan CJ; Kleinebudde P
    J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2018 Sep; 130():11-21. PubMed ID: 29913270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of implant composition of twin-screw extruded lipid implants on the release behavior.
    Even MP; Bobbala S; Kooi KL; Hook S; Winter G; Engert J
    Int J Pharm; 2015 Sep; 493(1-2):102-10. PubMed ID: 26188320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
    Schulze S; Winter G
    J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid extrusion of sustained release dosage forms.
    Reitz C; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release pathways of interferon α2a molecules from lipid twin screw extrudates revealed by single molecule fluorescence microscopy.
    Sax G; Feil F; Schulze S; Jung C; Bräuchle C; Winter G
    J Control Release; 2012 Sep; 162(2):295-302. PubMed ID: 22820452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of particle preparation methods and polymorphic stability of lipid excipients on protein distribution in microparticles.
    Liu J; Christophersen PC; Yang M; Nielsen HM; Mu H
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2032-2042. PubMed ID: 28756687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.
    Cheng L; Lei L; Guo S
    Int J Pharm; 2010 Mar; 387(1-2):129-38. PubMed ID: 20005928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.
    Christophersen PC; Zhang L; Yang M; Nielsen HM; Müllertz A; Mu H
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):473-80. PubMed ID: 23911434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2017 Aug; 117():244-255. PubMed ID: 28442372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of structural variations on drug release from lipid/polyethylene glycol matrices.
    Windbergs M; Strachan CJ; Kleinebudde P
    Eur J Pharm Sci; 2009 Jul; 37(5):555-62. PubMed ID: 19406229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein.
    Tang Y; Singh J
    Int J Pharm; 2009 Jan; 365(1-2):34-43. PubMed ID: 18786623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
    Yan X; He H; Meng J; Zhang C; Hong M; Tang X
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices.
    Dierickx L; Saerens L; Almeida A; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):683-9. PubMed ID: 22504402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.